Updated: Oct 16, 2009
Müllerian duct anomalies are an uncommon but often treatable cause of infertility. Patients with müllerian duct anomalies are known to have a higher incidence of infertility, repeated first-trimester spontaneous abortions, fetal intrauterine growth retardation, fetal malposition, preterm labor, and retained placenta. The role of imaging is to help detect, diagnose, and distinguish surgically correctable forms of müllerian duct anomalies from inoperable forms. In some correctable lesions, the surgical approach is altered based on imaging findings.1,2,3,4,5,6,7,8,9,10
Müllerian duct anomalies are estimated to occur in 0.1-0.5% of women. The true prevalence is unknown because the anomalies usually are discovered in patients presenting with infertility. Full-term pregnancies have occurred in patients with forms of bicornuate, septate, or didelphys uteri; therefore, true prevalence may be slightly higher than currently estimated. Simon et al found that in the healthy fertile population, müllerian duct anomalies have a prevalence of 3.2%.14
The presence of a müllerian duct anomaly is not associated with significantly increased mortality compared to the general population. Certain types of the anomaly can increase morbidity, such as in patients with obstructed or partially obstructed müllerian systems who present with hematosalpinx, hematocolpos, retrograde menses, and endometriosis [See also the eMedicine article Endometrioma/Endometriosis]. In addition, a fairly high association exists between müllerian duct anomalies and renal anomalies such as unilateral agenesis. Often, the anomalies are found only when dedicated renal imaging is performed after the müllerian abnormality is discovered; however, these patients most commonly present for medical attention because of infertility and repeated pregnancy loss.
Anomalies may be diagnosed in infancy, adolescence, or young adulthood. Female patients may present with a mass resulting from an obstructed müllerian system as infants (mucocolpos); with primary amenorrhea, mass (hematocolpos), or delayed onset of menarche as adolescents; or with problems of fertility and/or carrying pregnancy to term as adults.
Natural history and presentation
Embryology
Two paired müllerian ducts ultimately develop into the structures of the female reproductive tract. The structures include the fallopian tubes, uterus, cervix, and upper two thirds of the vagina. The ovaries and lower one third of the vagina have separate embryologic origins not derived from the müllerian system.
Complete formation and differentiation of the müllerian ducts into the segments of the female reproductive tract depend on completion of 3 phases of development as follows:
Ovaries and the lower vagina are not derived from the müllerian system. The ovaries are derived from germ cells that migrate from the primitive yolk sac into the mesenchyme of the peritoneal cavity and subsequently develop into ova and supporting cells. The lower vagina arises from the sinovaginal bulb, which fuses with the müllerian-derived upper two thirds to form the complete vagina.
Müllerian duct anomalies
Suggestion of a müllerian duct anomaly may arise in different clinical situations. In the newborn or infant, the initial presentation may be an obstructed system discovered as a palpable abdominal, pelvic, or vaginal mass (mucocolpos).15,16
Similarly, an adolescent girl may present to a clinician because of delayed menarche or because of an obstructed system presenting as an intra-abdominal mass (hematocolpos). Many patients also have cyclical pain.
Women of childbearing age often present with various problems of infertility, repeated spontaneous abortions, or premature delivery. As part of an infertility workup, routine imaging often detects the anomaly. Occasionally, the anomaly is discovered incidentally during imaging evaluation for another condition or during surgery such as elective sterilization.
Müllerian duct anomalies are categorized most commonly into 7 classes according to the American Fertility Society (AFS) Classification Scheme17 as follows:
Once a müllerian anomaly is suggested based on evidence from the patient history and physical examination, the clinician may opt for additional imaging workup. Imaging criteria for distinguishing forms of uterine anomalies are based on the configuration of the endometrial cavity—primarily on the configuration of the uterine fundus.27,28
Typically, the first examination ordered is a pelvic ultrasound (US) with transabdominal and, if feasible, transvaginal imaging. Müllerian duct anomalies may be suggested on transvaginal 2-dimensional (2D) sonographic imaging but may not be excluded on the basis of negative US findings. Newer 3-dimensional (3D) sonographic techniques offer relatively higher sensitivity and specificity (see Ultrasound).
Hysterosalpingography (HSG), performed under fluoroscopy, allows evaluation of the uterine cavity and tubal patency. Anomalies may be suggested but positive findings often are nonspecific for precise diagnosis (see Radiograph).
MRI is considered the criterion standard for imaging uterine anomalies. MRI provides high-resolution images of the uterine body, fundus, and internal structure. In addition, it can help evaluate the urinary tract for concomitant anomalies. In the past, intravenous urography was used for this purpose. Most types of uterine anomalies can be diagnosed confidently using pelvic MRI.
Although US is often the first imaging modality chosen because of its availability, short scan time, and low cost, several limitations are encountered during imaging. Image quality from transabdominal and transvaginal examinations is operator dependent. Overlying bowel gas can confound transabdominal imaging. Transvaginal imaging, although superior to the transabdominal approach, may not always be possible, as in patients with vaginal septa. Image resolution is a limiting factor.
HSG probably is the only imaging modality providing high-resolution imaging of the uterine cavity and fallopian tubes, but it is limited to imaging only the endoluminal contour; therefore, characterization of müllerian anomalies can be difficult. For example, visualization of 2 uterine cavities on HSG does not aid the radiologist in distinguishing septate, didelphys, and bicornuate uteri, which are 3 entities with radically different treatments. Since HSG uses ionizing radiation, ensure that the patient is not pregnant at the time of the examination. In patients who are not pregnant, ovaries receive a small dose of radiation, and the risk to the unfertilized ova is unknown.
MRI provides high-resolution images of the uterine cavity, the configuration of the uterus (body and fundus), and the ovaries. MRI is limited by motion artifact (patient movement, bowel peristalsis) and other features that degrade image quality (eg, metal prostheses, clips, filters) and cannot be performed in some patients (eg, patients who are claustrophobic, have pacemakers, or are obese).
Congenital renal anomalies
Amenorrhea (primary and secondary forms; diagnosed using endocrinologic blood work)
Before the advent of MRI and US, the primary imaging modality for evaluating uterine anomalies was limited to fluoroscopy or HSG. Fluoroscopic spot films are obtained after the cervix is cannulated and radiopaque contrast is injected into the uterine cavity.
HSG provides high-resolution images of the contour of the uterine cavity and fallopian tubes and remains the key imaging test for assessing tubal abnormalities that may cause infertility. Typically, the question of müllerian duct anomaly arises during HSG examination if the typical trigone configuration of the cavity is not demonstrated.
A common finding is separation of the uterine cavity into right and left compartments. A divided uterine cavity can result from septate, bicornuate, or didelphys uterus. Certain criteria are used to increase confidence in diagnosing 1 of the 3 entities.
A large overlap exists between the subtypes when comparing uterine cavitary configuration, intercornual distance, and intercornual angle. In several studies, HSG had significantly less accuracy for diagnostic precision than MRI or US. In the studies, much of the final pathology was based on laparoscopic or surgical findings, primarily of the appearance of the uterine fundus, which HSG was not able to assess.
Since HSG techniques did not provide diagnoses with high degrees of confidence, US and MRI soon began to play a larger role in assessment and treatment of patients. Currently, HSG has been all but abandoned as a primary modality for workup of potential congenital uterine anomalies. Anomalies incidentally discovered on HSG are referred for further evaluation using MRI or US.
The only anomaly in which HSG plays a significant role in diagnosis is DES uterus (AFS class VII). The abnormal uterine cavity can be depicted clearly on HSG but often is visualized as only uterine hypoplasia on US or MRI.
HSG findings commonly allow misdiagnoses of partial septate versus bicornuate uteri or complete septate versus bicornuate bicollis versus didelphys uteri because of the large degree of overlap in the intercornual distances and angles in the entities. While the specific diagnosis may be uncertain, an abnormality usually is clearly present (see Image below and Image 1 in Multimedia).
Examination protocol
MRI of the uterus (in benign conditions such as congenital anomalies or fibroid evaluation) is performed at the author's institution following administration of 1.0 mg IM of glucagon to decrease motion artifacts associated with bowel peristalsis. For the diagnosis of most anomalies, 5 main sequences are sufficient.
MRI appearance of müllerian anomalies (AFS classification system)
Class I (hypoplasia/agenesis): Findings of agenesis include absence of the uterus, cervix, and/or upper two thirds of the vagina. In uterine agenesis, no identifiable uterine tissue is noted. Partial agenesis of müllerian duct derivatives also can be visualized. In uterine hypoplasia, the endometrial cavity is small, with a reduced intercornual distance (<2 cm). When uterine hypoplasia is associated with hormonal dysfunction (infantile uterus), not only is the uterus small, but the zonal anatomy is differentiated poorly on T2-weighted images.
Class II (unicornuate uterus): Unicornuate uterus appears banana shaped without the usual rounded fundal contour and triangular appearance of the fundal cavity (see Image below and Image 9 in Multimedia). Uterine zonal anatomy is normal. If present, a rudimentary horn can be observed as a soft-tissue mass with signal intensity similar to that of myometrium. If obstructed, a rudimentary horn with functioning endometrium may be distended by blood or blood products.
Class III (didelphys uterus): Two separate normal-sized uteri and cervices are seen (see Image below and Image 8 in Multimedia). A septum may be visualized extending into the upper vagina. The 2 uterine horns are usually widely splayed, and endometrial and myometrial zonal widths are preserved. Vaginal septa are most commonly associated with this type but can be seen in the other anomalies.
Class V (septate uterus): The outer fundal contour is convex, flattened, or mildly concave (fundal cleft <1 cm; see Images below and Images 4-6 in Multimedia). The intercornual distance is usually normal (<4 cm), and each uterine cavity is usually small. The septum may be composed of muscle or fibrous tissue and is not a reliable means of distinguishing septate uterus from bicornuate uterus. A more reliable means for differentiating the 2 is to examine the fundal contour (see class IV). Differentiation between a septate and a bicornuate uterus is important because septate uteri are treated with transvaginal hysteroscopic resection of the septum, whereas if surgery is possible or indicated for the bicornuate uterus, an abdominal approach is required for metroplasty.
Class VI (arcuate uterus): MRI may detect this abnormality, but typically, it is not clinically significant because arcuate uterus has no significant negative effects on pregnancy outcome.
Class VII (DES related): MRI may detect this abnormality as a hypoplastic uterus. Typically, the DES-related anomaly is diagnosed confidently using HSG (see Radiograph).
MRI has consistently demonstrated high sensitivity and specificity for evaluation of uterine anomalies. Pellerito et al found MRI capable of helping correctly diagnose 24 of 24 anomalies (100% accuracy), compared to 11 of 12 anomalies (92%) detected on endovaginal sonography (EVS).29 For anomalies requiring surgery (unicornuate or bicornuate uteri), MRI demonstrated 100% sensitivity and specificity, compared to 67% sensitivity and 100% specificity for EVS. For nonsurgical lesions, both MRI and EVS had 100% sensitivity and specificity.
Pellerito et al also noted that MRI had the added advantage of detecting other incidental abnormalities, including a dermoid and submucosal leiomyoma, found on EVS to be indeterminate and nonvisualized, respectively.29
Data suggest very low false-negative and false-positive rates.
Examination protocol
Most commonly, 2D EVS is used to help evaluate uterine anatomy. Transabdominal 2D imaging may be performed, ideally through a distended bladder, but offers reduced sensitivity and specificity because of increased distance from the uterus and, often, intervening bowel. Preliminary studies indicate that 3D techniques in sonography may offer improved sensitivity and specificity for detection of uterine anomalies. Image quality for all techniques is highly operator dependent.
US appearance of müllerian anomalies (AFS classification system)
Some studies have found that 3D US is highly sensitive (up to 100%) and specific (up to 100%) in helping diagnose major müllerian anomalies.30 Studies have also found 2D transvaginal sonography to be a highly effective means of diagnosis, with 75-100% sensitivity and up to 95% specificity. Positive predictive value was higher with 3D scanning than with 2D scanning (100% vs 50%, respectively).
Nicolini et al found that transabdominal 2D US failed to visualize the uterine cavity adequately in as many as 35% of patients although it adequately imaged the uterine fundus in 90% of patients.31
In a study by Raga et al, 3D US detected 12 of 12 congenital uterine anomalies and correctly classified the anomalies according to AFS class in 11 of 12 patients. One false-negative result involved bicornuate uterus misdiagnosed as septate uterus because of a leiomyoma that caused the fundal contour to appear convex.32
Troiano RN, McCarthy SM. Mullerian duct anomalies: imaging and clinical issues. Radiology. Oct 2004;233(1):19-34. [Medline].
Kato H, Hayama M, Furuya S, Kobayashi S, Islam AM, Nishizawa O. Anatomical and histological studies of so-called Müllerian duct cyst. Int J Urol. May 2005;12(5):465-8. [Medline].
Shulman LP. Müllerian anomalies. Clin Obstet Gynecol. Jun 2008;51(2):214-22. [Medline].
Nichols JL, Bieber EJ, Gell JS. Case of sisters with complete androgen insensitivity syndrome and discordant Müllerian remnants. Fertil Steril. Mar 2009;91(3):932.e15-8. [Medline].
Olpin JD, Heilbrun M. Imaging of Müllerian duct anomalies. Clin Obstet Gynecol. Mar 2009;52(1):40-56. [Medline].
Ravel C, Lorenço D, Dessolle L, Mandelbaum J, McElreavey K, Darai E, et al. Mutational analysis of the WNT gene family in women with Mayer-Rokitansky-Kuster-Hauser syndrome. Fertil Steril. Apr 2009;91(4 Suppl):1604-7. [Medline].
Shirota K, Fukuoka M, Tsujioka H, Inoue Y, Kawarabayashi T. A normal uterus communicating with a double cervix and the vagina: a müllerian anomaly without any present classification. Fertil Steril. Mar 2009;91(3):935.e1-3. [Medline].
Soh E, Eleti A, Jimenez-Linan M, Arends MJ, Latimer J, Sala E. Magnetic resonance imaging findings of tamoxifen-associated uterine Müllerian adenosarcoma: a case report. Acta Radiol. Sep 2008;49(7):848-51. [Medline].
Acién P, Acién M, Sánchez-Ferrer ML. Müllerian anomalies "without a classification": from the didelphys-unicollis uterus to the bicervical uterus with or without septate vagina. Fertil Steril. Jun 2009;91(6):2369-75. [Medline].
Govindarajan M, Rajan RS, Kalyanpur A, Ravikumar. Magnetic resonance imaging diagnosis of Mayer-Rokitansky-Kuster-Hauser syndrome. J Hum Reprod Sci. Jul 2008;1(2):83-5. [Medline].
Ghi T, Casadio P, Kuleva M, Perrone AM, Savelli L, Giunchi S, et al. Accuracy of three-dimensional ultrasound in diagnosis and classification of congenital uterine anomalies. Fertil Steril. Aug 2009;92(2):808-13. [Medline].
Bean EJ, Mazur T, Robinson AD. Mayer-Rokitansky-Küster-Hauser Syndrome: Sexuality, Psychological Effects, and Quality of Life. J Pediatr Adolesc Gynecol. Jul 7 2009;[Medline].
Diehl CL, Gavrilova-Jordan LP, Coddington CC. Acute abdominal pain as a result of a ruptured hematosalpinx: a rare complication of an unusual müllerian anomaly. J Pediatr Adolesc Gynecol. Jun 2009;22(3):e9-11. [Medline].
Simon C, Martinez L, Pardo F, et al. Mullerian defects in women with normal reproductive outcome. Fertil Steril. Dec 1991;56(6):1192-3. [Medline].
Rehman A, Hasan Z, Amanat S, Shaukat T, Saeed A, Jamil K, et al. Combined persistent Mullerian Duct Syndrome, Transverse Testicular Ectopia and Mosaic Klinefelter's Syndrome. J Coll Physicians Surg Pak. Jun 2008;18(6):375-7. [Medline].
Kaufman Y, Lam A. The pelvic uterus-like mass--a primary or secondary Müllerian system anomaly?. J Minim Invasive Gynecol. Jul-Aug 2008;15(4):494-7. [Medline].
AFS. The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, mullerian anomalies and intrauterine adhesions. Fertil Steril. Jun 1988;49(6):944-55. [Medline].
Rosenberg HK, Sherman NH, Tarry WF, et al. Mayer-Rokitansky-Kuster-Hauser syndrome: US aid to diagnosis. Radiology. Dec 1986;161(3):815-9. [Medline].
Strubbe EH, Willemsen WN, Lemmens JA, et al. Mayer-Rokitansky-Kuster-Hauser syndrome: distinction between two forms based on excretory urographic, sonographic, and laparoscopic findings. AJR Am J Roentgenol. Feb 1993;160(2):331-4. [Medline].
Pittock ST, Babovic-Vuksanovic D, Lteif A. Mayer-Rokitansky-Küster-Hauser anomaly and its associated malformations. Am J Med Genet A. Jun 15 2005;135(3):314-6. [Medline].
Strissel PL, Oppelt P, Cupisti S, Stiegler E, Beckmann MW, Strick R. Assessment of pituitary and steroid hormones and members of the TGF-beta superfamily for ovarian function in patients with congenital uterus and vaginal aplasia (MRKH syndrome). Horm Metab Res. May 2009;41(5):408-13. [Medline].
Reichman D, Laufer MR, Robinson BK. Pregnancy outcomes in unicornuate uteri: a review. Fertil Steril. May 2009;91(5):1886-94. [Medline].
García González P, Meana Morís AR, Gracía Chapullé A, Matesanz Pérez JL. [The role of MRI in congenital cystic lesions in the pelvis: A case of uterus didelphys with double vagina, hematocolpos, and ipsilateral renal agenesis.]. Radiologia. Mar-Apr 2009;51(2):194-7. [Medline].
Mor E, Landay M, Paulson RJ. Endometrial receptivity is preserved in Diethylstilbestrol-associated and other Müllerian anomalies: evidence from tubal embryo transfer. J Assist Reprod Genet. Jan 2009;26(1):65-8. [Medline].
Rock JA, Adam RA. Surgery to repair disorders of development. In: Nichols DH, Clarke-Pearson, eds. Gynecologic, Obstetric, and Related Surgery. 2nd ed. St. Louis, Mo:. Mosby-Year Book;2000:780-813.
Acién P, Acién M, Romero-Maroto J. Blind hemibladder, ectopic ureterocele, or Gartner's duct cyst in a woman with Müllerian malformation and supposed unilateral renal agenesis: a case report. Int Urogynecol J Pelvic Floor Dysfunct. Jul 14 2009;[Medline].
Teo SY, Babagbemi KT, Peters HE, Mortele KJ. Primary malignant mixed mullerian tumor of the uterus: findings on sonography, CT, and gadolinium-enhanced MRI. AJR Am J Roentgenol. Jul 2008;191(1):278-83. [Medline].
Gutte AA, Pendharkar PS, Sorte SZ. Transverse testicular ectopia associated with persistent Mullerian duct syndrome - the role of imaging. Br J Radiol. Jul 2008;81(967):e176-8. [Medline].
Pellerito JS, McCarthy SM, Doyle MB, et al. Diagnosis of uterine anomalies: relative accuracy of MR imaging, endovaginal sonography, and hysterosalpingography. Radiology. Jun 1992;183(3):795-800. [Medline].
Jurkovic D, Geipel A, Gruboeck K, et al. Three-dimensional ultrasound for the assessment of uterine anatomy and detection of congenital anomalies: a comparison with hysterosalpingography and two-dimensional sonography. Ultrasound Obstet Gynecol. Apr 1995;5(4):233-7. [Medline].
Nicolini U, Bellotti M, Bonazzi B, et al. Can ultrasound be used to screen uterine malformations?. Fertil Steril. Jan 1987;47(1):89-93. [Medline].
Raga F, Bonilla-Musoles F, Blanes J, Osborne NG. Congenital Mullerian anomalies: diagnostic accuracy of three- dimensional ultrasound. Fertil Steril. Mar 1996;65(3):523-8. [Medline].
Carrington BM, Hricak H, Nuruddin RN, et al. Mullerian duct anomalies: MR imaging evaluation. Radiology. Sep 1990;176(3):715-20. [Medline].
Dunnick NR, Sandler CM, Newhouse JH, Amis ES. Textbook of Uroradiology. 3rd ed. Philadelphia, Pa:. Lippincott Williams & Wilkins;2000:45-8, 66-7.
Egan B. Congenital Uterine Anomalies. Hygeia Foundation for Perinatal Loss and Bereavement, Inc. 2(12). Available at: http://www.hygeia.org/poems24.uterine%20anomalies.htm. Available at www.hygeia.org/poems24.uterine%20anomalies.htm.
Giraldo JL, Habana A, Duleba AJ, Dokras A. Septate uterus associated with cervical duplication and vaginal septum. J Am Assoc Gynecol Laparosc. May 2000;7(2):277-9. [Medline].
Haimovici JBA, Tempany CMC. MR of the female pelvis: Benign disease. Applied Radiology [serial online]. 1997 Sept: 7-22. Available at: http://www.appliedradiology.com/articles/pdf/v0026i09/00800242/main.pdf. Available at http://www.appliedradiology.com/articles/pdf/v0026i09/00800242/main.pdf.
Hricak H. Female Pelvis: Anatomy & Benign Disease. Paper presented at:. The 3rd NICER HORIZON Urogenital Radiology Conference; 10-11 April 1999;Perth, Australia.
Wu MH, Hsu CC, Huang KE. Detection of congenital mullerian duct anomalies using three- dimensional ultrasound. J Clin Ultrasound. Nov-Dec 1997;25(9):487-92. [Medline].
müllerian duct abnormalities of the uterus, uterine, female reproductive tract, müllerian congenital uterine anomalies, müllerian anomalies, müllerian duct anomalies, Mayer-Rokitansky-Kuster-Hauser syndrome, female reproductive tract developmental abnormalities, paramesonephric developmental abnormalities
Ibrahim Syed, MD,, Clinical Assistant Professor of Diagnostic Radiology, Volunteer Faculty, University of Toledo Medical Center; Consulting Staff Radiologist, Vista Health System, Waukegan, IL
Ibrahim Syed, MD, is a member of the following medical societies: American College of Radiology, American Medical Association, American Roentgen Ray Society, Illinois State Medical Society, and Radiological Society of North America
Disclosure: Nothing to disclose.
Hero K Hussain, MD, FRCR, Associate Professor of Radiology, Director of Clinical MR Services, Chief of Body MRI Section, Department of Radiology, University of Michigan Health Service
Hero K Hussain, MD, FRCR is a member of the following medical societies: American Roentgen Ray Society, International Society for Magnetic Resonance in Medicine, Radiological Society of North America, and Society of Uroradiology
Disclosure: Nothing to disclose.
William Weadock, MD, Associate Professor of Radiology, Department of Radiology, University of Michigan Medical Center
William Weadock, MD is a member of the following medical societies: American Medical Association, American Roentgen Ray Society, and Radiological Society of North America
Disclosure: Nothing to disclose.
James Ellis, MD, Professor of Radiology and Urology, University of Michigan
James Ellis, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Radiology, American Roentgen Ray Society, Association of University Radiologists, Radiological Society of North America, and Society of Uroradiology
Disclosure: Nuance Inc. Honoraria Consulting; GE Healthcare None Unpaid research investigator; Legal firm representing GE Healthcare Consulting fee Consulting
Christopher L Sistrom, MD, Associate Chair for Research, Assistant Professor, Department of Radiology, University of Florida School of Medicine
Christopher L Sistrom, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Radiology, American Institute of Ultrasound in Medicine, American Roentgen Ray Society, Association of University Radiologists, Phi Beta Kappa, and Radiological Society of North America
Disclosure: Nothing to disclose.
Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.
Karen L Reuter, MD, FACR, Professor, Department of Radiology, Lahey Clinic Medical Center
Karen L Reuter, MD, FACR is a member of the following medical societies: American Association for Women Radiologists, American College of Radiology, American Institute of Ultrasound in Medicine, American Roentgen Ray Society, and Radiological Society of North America
Disclosure: Nothing to disclose.
Robert M Krasny, MD, Resolution Imaging Medical Corporation
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.
Eugene C Lin, MD, Consulting Radiologist, Virginia Mason Medical Center; Clinical Assistant Professor of Radiology, University of Washington School of Medicine
Eugene C Lin, MD is a member of the following medical societies: American College of Nuclear Medicine, American College of Radiology, Radiological Society of North America, and Society of Nuclear Medicine
Disclosure: Nothing to disclose.